Time-course of Treatment-emergent Adverse Events Potentially Associated with Behavioral Disorders during Adjunctive Brivaracetam Treatment of Adults with Focal Seizures

被引：0
|
作者：
Meador, Kimford J. [1 ]
Dimova, Svetlana [2 ]
Laloyaux, Cedric [2 ]
Nondonfaz, Xavier [2 ]
Floricel, Florin [2 ]
Elmoufti, Sami [2 ]
Klein, Pavel [3 ]
机构：
[1] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA
[2] UCB Pharma, London, England
[3] Mid Atlantic Epilepsy & Sleep Ctr, London, England
来源：
NEUROLOGY | 2022年 / 98卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P17-8.003
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures
    Brandt, Christian
    Dimova, Svetlana
    Elmoufti, Sami
    Laloyaux, Cedric
    Nondonfaz, Xavier
    Klein, Pavel
    EPILEPSY & BEHAVIOR, 2023, 138
  • [32] Effectiveness During 12-Month Adjunctive Brivaracetam Treatment in Patients with Focal-Onset Seizures in a Real-Life Setting: A Prospective, Observational Study in Europe
    Steinhoff, Bernhard J.
    Christensen, Jakob
    Doherty, Colin P.
    Majoie, Marian
    Schulz, Anne-Liv
    Brock, Fiona
    Bourikas, Dimitrios
    Leunikava, Iryna
    Kelemen, Anna
    Rubio-Nazabal, Eduardo
    NEUROLOGY AND THERAPY, 2025, 14 (02) : 627 - 642
  • [33] Incidence of Treatment-emergent Adverse Events According to Baseline Antiepileptic Drug Use: A Pooled Analysis of Data from Phase II/III Trials of Adjunctive Eslicarbazepine Acetate in Children
    Wirrell, E.
    Conry, J.
    Grinnell, T.
    Cantu, D.
    Gama, H.
    Rocha, T.
    Li, Y.
    Blum, D.
    ANNALS OF NEUROLOGY, 2018, 84 : S342 - S343
  • [34] Treatment satisfaction, work productivity, and quality of life under adjunctive brivaracetam in earlier treatment lines in adults with focal- onset seizures: 12-month real-world data from BRITOBA
    Winter, Y.
    Boero, G.
    Didato, G.
    Didelot, A.
    Hirsch, E.
    Kuehn, F.
    Navarro, V.
    Rehel, B.
    Schulz, A-L
    Leunikava, I.
    EPILEPSIA, 2024, 65 : 178 - 179
  • [35] Treatment-Emergent Adverse Events (TEAEs) by Age for Patients with Lennox-Gastaut Syndrome (LGS) Treated with Clobazam during Phase II/III Trials
    Isojarvi, Jouko
    Lee, Deborah
    Buchhalter, Jeffrey
    NEUROLOGY, 2013, 80
  • [36] TIME COURSE OF TREATMENT-RELATED ADVERSE EVENTS (TRAES) DURING DOSTARLIMAB THERAPY IN THE GARNET TRIAL
    Pothuri, Bhavana
    Berton, Dominique
    Moreno, Victor
    Oaknin, Ana
    Perez, Jose Manuel Trigo
    Curigliano, Giuseppe
    Ellard, Susan
    Pikiel, Joanna
    Banerjee, Susana
    Barretina-Ginesta, Maria-Pilar
    Miller, Rowan
    Tinker, Anna
    Jewell, Andrea
    Plummer, Ruth
    Joly, Florence
    Veneris, Jennifer
    Duan, Tao
    Andre, Thierry
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A398 - A398
  • [37] Post Hoc Analysis of Time to Sustained 50[percnt] Responder Status in Three Phase III Studies of Brivaracetam (BRV) as Adjunctive Treatment for Partial-Onset (Focal) Seizures (POS)
    Klein, Pavel
    Johnson, Martin
    Schiemann, Jimmy
    Whitesides, John
    NEUROLOGY, 2016, 86
  • [38] Health-Related Quality of Life and Cognitive Performance During 12-Month Adjunctive Brivaracetam Treatment in Patients with Focal-Onset Seizures: A Prospective, Observational Study in Europe
    Rubio-Nazabal, Eduardo
    Majoie, Marian
    Schulz, Anne-Liv
    Brock, Fiona
    Leunikava, Iryna
    Bourikas, Dimitrios
    Steinhoff, Bernhard J.
    NEUROLOGY AND THERAPY, 2025, 14 (02) : 609 - 625
  • [39] TIME COURSE OF ADVERSE EVENTS DURING DOSTARLIMAB TREATMENT IN PATIENTS WITH RECURRENT OR ADVANCED ENDOMETRIAL CANCER IN THE GARNET TRIAL
    Oaknin, A.
    Gilbert, L.
    Tinker, A.
    Guo, W.
    Im, E.
    Pothuri, B.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A74 - A74
  • [40] Brivaracetam adjunctive therapy in earlier treatment lines in adults with focal-onset seizures in Europe and Canada: Second interim results of 12-month real-world data from BRITOBA
    Knake, S.
    De Curtis, M.
    Kobayashi, E.
    Lema-Facal, T.
    Maillard, L-G
    Rehel, B.
    Rheims, S.
    Schulz, A-L
    Leunikava, I.
    EPILEPSIA, 2024, 65 : 170 - 171
12345